Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome-Reference-Cited by-同舟云学术

Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome

Published:2008-04 Issue:4 Volume:14 Page:418-425
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Armand Philippe,Kim Haesook T.,Ho Vincent T.,Cutler Corey S.,Koreth John,Antin Joseph H.,LaCasce Ann S.,Jacobsen Eric D.,Fisher David C.,Brown Jennifer R.,Canellos George P.,Freedman Arnold S.,Soiffer Robert J.,Alyea Edwin P.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. Allogeneic transplantation in lymphoma: current status;Schmitz;Haematologica,2007

2. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation;Peniket;Bone Marrow Transplant,2003

3. Comparison of autologous and allogeneic hematopoietic stem cell transplantation for follicular lymphoma;van Besien;Blood,2003

4. Syngeneic Hematopoietic Stem-Cell Transplantation for Non-Hodgkin’s Lymphoma: A Comparison With Allogeneic and Autologous Transplantation—The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

5. Longer follow-up confirms a low relapse rate after non-myeloablative allogeneic transplantation (NMT) for non-Hodgkin's lymphoma (NHL), including patients with PET or gallium-avid disease;Khouri;Blood,2005

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Tender Reduced-Intensity Conditioning for the Unfit: A Novel 4 Gy Total Body Irradiation-Based Conditioning Followed by Two-Step Haploidentical Stem Cell Transplant, Results of a Prospective Trial;Transplantation and Cellular Therapy;2024-07

2. The two-step approach to allogeneic hematopoietic stem cell transplantation;Frontiers in Immunology;2023-09-01

3. Safety and efficacy of immune checkpoint inhibitors after allogeneic hematopoietic cell transplantation;Bone Marrow Transplantation;2023-07-29

4. The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy;Frontiers in Medicine;2022-12-06

5. Checkpoint Inhibitors and the Changing Face of the Relapsed/Refractory Classical Hodgkin Lymphoma Pathway;Current Oncology Reports;2022-06-13